Population
Patients with advanced or end-stage heart failure
Design
Review
Key result
Left ventricular assist device therapy for advanced heart failure has evolved significantly, with mean survival following implantation now reaching nearly 5 years.
Authors
Loading...
Enhances survival outlook for advanced HF; leaves open strategies to reduce persistent complications.
LVAD therapy has evolved significantly, providing nearly 5 years of mean survival for advanced heart failure patients, though complications remain a limitation.
Miller et al. (2018) conducted a review in Advanced heart failure. Left ventricular assist devices was evaluated. Left ventricular assist device therapy for advanced heart failure has evolved significantly, with mean survival following implantation now reaching nearly 5 years.